What will a no-deal Brexit mean for pharma and health care?

Pharmaphorum

7 February 2019 - Britons are bracing themselves for the UK’s imminent departure from the European Union. A worst-case scenario would see our country leave without a deal. 

Prime minister Theresa May’s Brexit offer has been defeated in the House of Commons – by more than 230 votes. It was the biggest defeat on a piece of government legislation in modern history.

And one sector which could suffer if a deal isn’t passed is healthcare. A no-deal Brexit threatens the future of the NHS, puts a significant strain on staffing numbers, and poses a risk to the future of research and medical development.

Last week, the government outlined plans for EU citizens wishing to come to the UK in the event of a no-deal Brexit. ‘Temporary Leave to Remain’ grants them the same rights as they have now: they can live, work and study freely. But it only lasts for three years and there is no extension beyond this point. Those who wish to stay will have to apply for Indefinite Leave to Remain or apply for a Tier 2 Visa. That could be a long, arduous and expensive process.

Read Pharmaphorum article

Michael Wonder

Posted by:

Michael Wonder